Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2689-2694
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2689
Table 1 Patient characteristics n (%)
FactorsP value
Age (yr), median (range)52 (28–75)0.3509
Sex< 0.001
Male133 (95.0)
Female7 (5.0)
Level of education< 0.0001
Primary school20 (14.0)
Secondary school56 (40.0)
Commercial or vocational school64 (46.0)
Tumor, node, metastasis stage
I49 (35.0)0.0023
II35 (25.0)
IIIA29 (20.7)
IIIB27(19.3)
IIIC0
IV0
Etiology
Hepatitis B135 (96.5)
Hepatitis C2 (1.4)
Alcoholic2 (1.4)
Cryptogenic1 (0.7)
Child-Pugh class
A84 (60.0)
B29 (20.7)
C27 (19.3)
Table 2 Functional assessment of cancer therapy-hepatobiliary mean scores (n =140)
FACT-Hep subscalesmean ± SDSum of scoresFP value
PWB16.47 ± 4.27276.8616.990.000
SFWB14.52 ± 3.3537.081.710.184
EWB12.74 ± 3.39131.337.110.001
FWB17.57 ± 3.93165.325.840.004
HepCS41.46 ± 9.52754.795.720.004
Table 3 Functional assessment of cancer therapy-hepatobiliary subscale results by tumor node metastasis stage of hepatocellular carcinoma and by Child-Pugh class (mean ± SD)
nPWBSFWBEWBFWBHepCS
TNM stage
I4921 ± 2.15df15.81 ± 3.6815.11 ± 2.79df19.96 ± 3.20df48.52 ± 8.36df
II3519.07 ± 3.41bf14.69 ± 2.8213.38 ± 3.01b19.24 ± 2.21b45.45 ± 10.01b
IIIA2916.29 ± 2.24bd14.66 ± 3.313.06 ± 3.08b18.37 ± 3.98b41.29 ± 7.05b
IIIB2712.41 ± 2.88bdf13.61 ± 3.32a10.84 ± 3.15bdf14.69 ± 3.39bd35.35 ± 7.44bd
Child-Pugh class
A7319.56 ± 2.7915.29 ± 3.3414.12 ± 2.8919.58 ± 3.26j46.12 ± 8.79j
B4016.65 ± 2.79h14.25 ± 3.0811.8 ± 3.0516.48 ± 2.98h38.88 ± 6.61h
C2710.52 ± 2.41h12.85 ± 3.21h10.41 ± 3.49hj13.78 ± 3.48hj32.7 ± 7.38hj